Trial NCT04099888

View at ClinicalTrials.gov 
Org. Study IDs: PCIA 203/18

Last trial update was posted on 2023-09-11

MeSH Interventions

Gemcitabine

MeSH Conditions

Cholangiocarcinoma

Other Conditions


Stopping Reasons

Recent results from a Phase 3 study are expected to change the standard of care for patients with inoperable CCA, rendering the RELEASE study challenging to complete and potentially inadequate for NDA approval.

Limitations And Caveats

Due to the early termination of this study, no definitive conclusions can be drawn since an insufficient number of participants was recruited. A reduced statistical analysis was conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID